ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Mar 2025
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
March 2025
Nuclear Technology
Fusion Science and Technology
April 2025
Latest News
Nuclear News 40 Under 40 discuss the future of nuclear
Seven members of the inaugural Nuclear News 40 Under 40 came together on March 4 to discuss the current state of nuclear energy and what the future might hold for science, industry, and the public in terms of nuclear development.
To hear more insights from this talented group of young professionals, watch the “40 Under 40 Roundtable: Perspectives from Nuclear’s Rising Stars” on the ANS website.
Isao Murata, Shingo Tamaki, Sachie Kusaka, Indah Rosidah Maemunah, Fuminobu Sato, Hiroyuki Miyamaru, Shigeo Yoshida
Fusion Science and Technology | Volume 79 | Number 4 | May 2023 | Pages 465-475
Technical Paper | doi.org/10.1080/15361055.2022.2151280
Articles are hosted by Taylor and Francis Online.
A fusion reactor is known as a neutron-rich nuclear energy source. In this paper, neutrons are utilized to form an epithermal neutron irradiation field for boron neutron capture therapy (BNCT). Using the International Thermonuclear Experimental Reactor (ITER) facility, a beam shaping assembly (BSA) was designed and placed just before the biological shield. Treatments were planned to be carried out just outside the biological shield. An opening was prepared in the vacuum vessel to guide deuteron-triton neutrons to the BSA. The BSA is about 1 m in thickness, and on the outside surface of the BSA, an epithermal neutron flux of 1 × 109 n/s‧cm−2 was aimed. As a result of the design, the irradiation field successfully met the design criteria of the BSA advocated by the International Atomic Energy Agency. The BSA moderator consists of a first filter of 45-cm-thick iron and a second filter of 70-cm-radius and 40-cm-thick AlF3. The epithermal neutron beam was available for diameters from 10 to 20 cm to cope with various sizes of tumors. Also, a titanium layer was specially introduced to remove fast neutrons just above 10 keV to reduce the fast neutron contribution. In addition, a caldera-shaped collimator was set just outside of the BSA to form a broad beam and to make the current-to-flux ratio larger than 0.7. It was shown from the present design that the performance was confirmed to be excellent compared to other BNCT facilities available at present, meaning that even deep-seated cancer treatment could be realized in the future in ITER.